CVS Health Corporation

NYSE:CVS

Medical - Healthcare Plans

Healthcare
$81.35 -0.59%

-$0.59 today

Market cap
$104.08B
Beta
0.62
P/E (TTM)
42.8
EPS (TTM)
$2.30
Dividend yield
2.70%
52W Low $58.50High $102.77

Volume 17.19M

Average 8.19M

CVS Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

CVS Health CorporationNYSE: CVS

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 14.8%

Gross margin was 14.8% in Q2 FY2026, up 1.1 pp from a year earlier. On a trailing-twelve-month basis it was 14.2%, up 0.3 pp year over year. Over 3 fiscal years it narrowed by 3.1 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
14.8%-0.7 pp QoQ
Last fiscal yearDec 2025
13.8%-0.0 pp YoY
LTMJun 2026
14.2%+0.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.1 pp——
1 year-0.0 pp——
3 years-3.1 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
13.8%
Year-over-year change
-0.0pp

Gross Margin vs competitors

How CVS compares with its peers on the latest reported figures

  • CVS's LTM Jun 2026 gross margin of 14.2% is the 5th highest of the 9 companies compared; the peer median is 14.6%.
  • Its year-over-year change of +0.3 pp is the 6th highest of 9, against a peer median of +2.0 pp.
  • Over three fiscal years its change of -3.1 pp compares with a peer median of -3.4 pp.
CVS Competitors Peer median
Gross Margin for CVS and competitors
Company Period LTM level YoY 3-year change
OSCROscar Health, Inc.LTM Jun 202644.9% +9.0 pp-85.6 pp
ELVElevance Health Inc.LTM Sep 202636.6% +10.3 pp+0.0 pp
UNHUnitedHealth Group IncorporatedLTM Sep 202622.8% +3.1 pp-6.0 pp
CNCCentene CorporationLTM Jun 202616.1% +7.2 pp+0.7 pp
CVSCVS Health CorporationLTM Jun 202614.2% +0.3 pp-3.1 pp
HUMHumana Inc.LTM Sep 202613.0% -1.9 pp-4.0 pp
ALHCAlignment Healthcare, Inc.LTM Mar 202612.4% +0.8 pp-0.5 pp
CICigna CorporationLTM Sep 202610.3% +0.2 pp-3.6 pp
MOHMolina Healthcare, Inc.LTM Sep 20268.1% -2.0 pp-3.3 pp
Peer median (excluding CVS) 14.6%+2.0 pp-3.4 pp

Competitors are the stored peer set for CVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue292.11B322.47B357.78B372.81B402.07B
Cost of Revenue239.99B267.97B303.35B321.41B346.71B
Gross Profit52.12B54.5B54.43B51.4B55.36B
Gross Margin17.8%16.9%15.2%13.8%13.8%
Research & Development00000
Selling, General & Admin00041.23B0
Operating Expenses38.81B46.55B40.69B42.89B44.98B
Depreciation & Amortization4.49B4.22B4.37B4.6B4.61B
EBITDA17.53B12.35B18.2B13.68B9.86B
EBITDA Margin6.0%3.8%5.1%3.7%2.5%
Operating Income13.31B7.95B13.74B8.52B10.39B
Operating Margin4.6%2.5%3.8%2.3%2.6%
Interest Income00000
Interest Expense2.5B2.29B2.66B2.96B3.12B
Other Income / Expenses(2.77B)(2.12B)(2.57B)(2.37B)(8.25B)
Income Before Tax10.54B5.84B11.17B6.15B2.14B
Pre-Tax Margin3.6%1.8%3.1%1.6%0.5%
Income Tax Expense2.55B1.51B2.81B1.56B408M
Net Income8B4.31B8.34B4.61B1.77B
Net Margin2.7%1.3%2.3%1.2%0.4%
EPS (Basic)6.003.296.493.661.40
EPS (Diluted)5.953.266.473.661.39
Weighted Avg Shares1.32B1.31B1.29B1.26B1.27B
Weighted Avg Shares (Diluted)1.33B1.32B1.29B1.26B1.27B

CVS Health Corporation

NYSE:CVS

Intrinsic Alpha fair value

Locked

Current Price

$81.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.